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The emergence of drug-resistant pathogens has prompted the search for new antibacterials. In this issue of
Chemistry & Biology, Starosta et al. identify specific thiopeptide-antibiotic precursor lead compounds using
three complementary high-throughput translation machinery assays.The ribosome is a major target for antibi-
otic action.Many natural antibiotics inhibit
cell growth by binding to the ribosome
and inhibiting protein synthesis (Sutcliffe,
2005). They have served as the quintes-
sential drugs used to combat bacterial
infections. However, the spread of resis-
tant strains has become a real threat
(Walsh, 2009), creating a need for strate-
gies that allow the rapid identification
and evaluation of fresh antibiotic leads.
This is not an easy task, since a variety
of different interaction modes between
the antibiotic and the ribosome are
possible (e.g., see Moroder et al. (2009)
or Ramu et al. (2009)). The detailed struc-
tural characterization of the interaction
is laborious and time consuming, and
although revealing the three-dimensional
details of antibiotic-ribosome binding
can be helpful in combinationwithmodern
computational methods to find new
potential leads (Wimberly, 2009), such
structure-based drug design (SBDD) is
not always successful. Moreover, SBDD
usually relates very close to the original
scaffold and location of ribosome inter-
action. A different, functionally driven
approach has been chosen by Starosta
et al. (2009). The authors have focused
on one class of antibiotics, namely thio-
peptides, which are remarkable natural
products with thiostrepton as the flagship
member. The structural complexity and
biological properties have made thiopep-
tides one of the most attractive targets
for chemists engaged in total synthesis
(Nicolaou and Montagnon, 2008). Star-
osta et al. (2009) have recognized the
potential of thiopeptide-based fragment
libraries derived from retrosynthetic anal-
ysis of thiopeptides. Together with their
synthetic chemistry colleague David
Chen, the authors set out to validate the1024 Chemistry & Biology 16, October 30, 2potential of these fragments as novel anti-
biotic scaffolds by establishing three func-
tional assays (Figure 1). All three assays
represent in vitro ribosomal set-ups that
addressdistinct steps of translation; these
involve: (i) monitoring of 30S initiation
complex (30SIC) versus 70S initiation
complex (70SIC) formation by a fluores-
cently labeled IF2derivative, (ii)monitoring
of GTPase activity either via colorimetric
detection of inorganic phosphate forma-
tion or detection of inorganic phosphate
binding toafluorescentderivativeof phos-
phate-binding protein, and (iii) monitoring
of GFP production in a coupled transcrip-
tion and translation system. Based on
these assays, the authors screened sepa-
rate fragment libraries of thiostrepton,
nosiheptide,micrococcin,andGE2270A/T
antibiotics. The promising outcome of the
high-throughput study was the identifica-
tion of four distinct families of thiopeptide
precursor compounds with significant
inhibitory properties and/or competitive
inhibitory effects to their related full-size
antibiotics (for further details, seeStarosta
et al. (2009)).
The urgent need for efficient functional
assays for lead compound identification
is not only reflected by the present work.
Along these lines, another novel tool for
analyzing antibiotic interaction has been
described by Mankin and coworkers very
recently (Llano-Sotelo et al., 2009). Their
assay relies on ribosomes that carry
a site-specific fluorescent label covalently
attached to one of the ribosomal proteins.
Moreover, the efforts of pharmaceutical
companies on ribosome-based screen-
ings to identify novel antibiotics have
been reported on tracking bacterial tRNA
synthetase activity using an E. coli S30-
based transcription and translation assay
(Dermyer et al., 2007). High-throughput009 ª2009 Elsevier Ltd All rights reservedscreeningassays for inhibitionofelongation
factor P and ribosomal peptidyl transferase
activity using Staphylococcus aureus EF-P
and a reconstituted E. coli ribosomal
system represent another recent example
(Swaney et al., 2006).
The incidence of antibiotic resistance
has made the discovery of new scaffolds
to a primary goal in antibiotic research.
Besides mining underexplored microbial
niches for natural products, repurposing
libraries of synthetic molecules by func-
tionally driven assays that address their
suspectedmolecular targetswill contribute
significantly to reach this aim.
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PreviewsFigure 1. Identification of Lead Compounds Derived from Thiopeptide Antibiotics
(A) Thiostrepton is the most prominent member of the thiopeptide family, active against Gram-positive
bacteria, and was used in veterinary medicine for many years. Structure of thiostrepton (left) and fragment
compounds derived from retrosynthetic analysis (right).
(B) The urgent need for functional ribosomal assays in modern drug design is exemplified by Starosta et al.
(2009) in a study published in this issue of Chemistry & Biology. They demonstrate the identification of
thiopeptide fragments with inhibitory effects based on high-throughput ribosomal assays that target
specific steps of the translation apparatus as indicated above.Chemistry & Biology 16, October 30, 2009 ª2009 Elsevier Ltd All rights reserved 1025
